½ÃÀ庸°í¼­
»óǰÄÚµå
1532875

¼¼°èÀÇ ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå : ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)

Neuroscience Antibodies & Assays Market, By Technology, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 260 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¼¼°èÀÇ ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 42¾ï 932¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö CAGR 10.90%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå-½ÃÀå ¿ªÇÐ

½Å°æÁúȯ À¯º´·ü Áõ°¡ ¹× »ý¸í°øÇÐ »ê¾÷ ÅõÀÚ°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ Àü¸Á

¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´, °£Áú µîÀÇ ½Å°æÁúȯÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Áúȯ°ú °ü·ÃµÈ ¹ÙÀÌ¿À¸¶Ä¿¸¦ Á¤È®ÇÏ°Ô °ËÃâ ¹× ¿¬±¸ÇÒ ¼ö ÀÖ´Â µµ±¸ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ºÐ¼®Àº Áúº´ ¸ÞÄ¿´ÏÁò¿¡ °ü¿©Çϴ ƯÁ¤ ´Ü¹éÁú, ½Å°æÀü´Þ¹°Áú ¹× ±âŸ ºÐÀÚÀÇ µ¿Á¤°ú Á¤·®À» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ÀÌ Á¶»ç¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Ç×ü °³¹ß, ºÐ¼® ±â¼ú ¹× À̹Ì¡ ±â¼úÀÇ ²÷ÀÓ¾ø´Â Áøº¸·Î ½Å°æ °úÇÐ ºÐ¼®ÀÇ °¨µµ, ƯÀ̼º ¹× ´ÙÁßÈ­ ´É·ÂÀÌ ÇöÀúÇÏ°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ½Å°æ Áúȯ¿¡ ÃÊÁ¡À» ¸ÂÃá ±âÃÊ ¿¬±¸¿Í ÀǾàǰ °³¹ß ¸ðµÎ¿¡¼­ ÀÀ¿ë ºÐ¾ß°¡ ³Ð¾îÁý´Ï´Ù.

°Ô´Ù°¡ »ý¸í°øÇаú Á¦¾à±â¾÷¿¡ ÀÇÇÑ ½Å°æ°úÇÐ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí Ç×ü¿Í ºÐ¼®°ú °°Àº ½Å·ÚÇÒ ¼ö ÀÖ´Â µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ È¸»çµéÀº â¾à Ç¥ÀûÀÇ °ËÁõ, ÀáÀçÀû Ä¡·áÁ¦ÀÇ ½ºÅ©¸®´×, ÀüÀÓ»ó ¹× ÀÓ»ó½ÃÇè¿¡¼­ÀÇ Ä¡·áÈ¿°úÀÇ Æò°¡¿¡ À־ °ß°íÇÑ ºÐ¼®¿¡ ÀÇÁ¸ÇÕ´Ï´Ù. µû¶ó¼­ ±â¼úÀû Áøº¸, ÀÓ»ó ¿ä±¸, °æÁ¦Àû Àμ¾Æ¼ºê°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå-ÁÖ¿ä ÀλçÀÌÆ®

¿ì¸® ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â)¿¡ ¾à 10.90%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

±â¼úº°·Î, ¿þ½ºÅÏ ºí·ÎÆÃ ¹× ±âŸ ¸é¿ªÇÐÀû Áúº´ÀÇ ³ôÀº À¯ÇàÀº ¸é¿ªºÐ¼® ºÎ¹®ÀÌ 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» ³ªÅ¸³½ °ÍÀ¸·Î Æò°¡µÇ¾ú½À´Ï´Ù.

¿ëµµº°·Î´Â ½Å°æ°úÇаú ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¿ëµµÀÇ ¿¬±¸ Áõ°¡¿¡ ÀÇÇØ â¾à ¹× ¿¬±¸°³¹ß ºÎ¹®ÀÌ 2023³âÀÇ ÁÖ¿ä ¿ëµµ¿´½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¹× Á¦¾à ±â¾÷À¸·ÎºÎÅÍÀÇ ÅõÀÚ Áõ°¡·Î 2023³â¿¡´Â Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö±â¾÷ ºÎ¹®ÀÌ ÃÖÁ¾ »ç¿ëÀÚÀÇ ÅéÀ̾ú½À´Ï´Ù.

Áö¿ªº°·Î´Â ÀÓ»óÁø´Ü¿¡¼­ ½Å°æ°úÇп¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ̾ú½À´Ï´Ù.

½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå-ºÎ¹® ºÐ¼® :

¼¼°èÀÇ ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀåÀº ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°·Î ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ±â¼úº°·Î ¸é¿ªºÐ¼®, ºÐÀÚÁø´Ü, ÀÓ»óÈ­ÇÐ, ±âŸ ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ½ÃÀåÀ» µ¶Á¡ÇÏ´Â °ÍÀº ¸é¿ª ºÐ¼® ºÎ¹®ÀÔ´Ï´Ù. ELISA¿Í ¿þ½ºÅÏ ºí·ÎÆÃ À¯Çü ¼ö¿ä°¡ ³ôÀº °ÍÀÌ ÀÌ ºÐ¾ßÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¿ëµµº°·Î â¾à ¹× °³¹ß, ü¿Ü Áø´Ü, ¿¬±¸ÀÇ 3°¡Áö·Î ºÐ·ùµË´Ï´Ù. â¾à ¹× °³¹ß ºÐ¾ß°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ½Å¾àÀÇ ¹ß°ß°ú ÀÓ»ó Áø´Ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº°·Î Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ¿¬±¸±â°ü, º´¿øÀÇ 3°³·Î ºÐ·ùµË´Ï´Ù. Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ³ôÀº ¿ìÀ§¼ºÀ» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦¾àȸ»ç´Â ½Å°æ°úÇаú ¿¬±¸¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç ½ÃÀå ¼ö¿ä¸¦ º¸¿ÏÇϰí ÀÖ½À´Ï´Ù.

½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå-Áö¸®Àû ÀλçÀÌÆ®

Áö¸®ÀûÀ¸·Î, ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¢ Áö¿ªÀ¸·Î ÆÛÁ® ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀåÀÇ, ƯÈ÷ ¹Ì±¹¿¡¼­ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÀÌÁ¡Àº ÁÖ¿ä Á¦¾à ±â¾÷ ¹× »ý¸í °øÇÐ ±â¾÷ÀÇ Á¸Àç, NIH¿Í °°Àº Á¤ºÎ ±â°üÀÇ ±¤¹üÀ§ÇÑ Á¶»ç ±â±Ý, È®¸³µÈ ÀÇ·á ÀÎÇÁ¶ó¿¡ ±âÀÎÇÕ´Ï´Ù.

½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå-°æÀï ±¸µµ :

½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀåÀÇ °æÀïÀº Áß°£ Á¤µµÀÔ´Ï´Ù. ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀåÀÇ ±â¾÷Àº Á¦Ç°ÀÇ ¼º´ÉÀ» ³ôÀÌ°í ¿¬±¸ÀÚÀÇ ÁøÈ­ÇÏ´Â ¿ä±¸¿¡ ´ëÀÀÇϱâ À§ÇØ ²÷ÀÓ¾øÀÌ ±â¼ú Çõ½ÅÀ» ½Ç½ÃÇß½À´Ï´Ù. ½ÃÀå ÁøÃâ ±â¾÷Àº Àü·«Àû ÆÄÆ®³Ê½Ê°ú Á¦ÈÞ¸¦ ¸Î¾î Á¦Ç° ¶óÀξ÷°ú ½ÃÀå ÁøÀÔ È®´ë¸¦ µµ¸ðÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ ½ÃÀå ÁøÃâ ±â¾÷Àº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç µî ÁÖ¿ä ½ÃÀå¿¡¼­ Á¦Ç° °ø±Þ°ú °í°´ Áö¿øÀ» °­È­Çϱâ À§ÇØ À¯Åë ä³Î¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤³â

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ºÐ¼®
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ½ÃÀåÀÇ ¹Ì·¡ µ¿Çâ

Á¦4Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ »ê¾÷ ¿¬±¸

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÊÇÎ
  • ±ÔÁ¦ Ʋ ºÐ¼®

Á¦5Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå »óȲ

  • ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ÀÇ ºÐ¼®
    • ½ÅÈï ±â¾÷ÀÇ ºÐ¼®

Á¦7Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå : ±â¼úº°

  • °³¿ä
    • ºÎ¹® Á¡À¯À² ºÐ¼® : ±â¼úº°
    • À̳ð °ËÁ¤
    • ºÐÀÚÁø´Ü
    • ÀÓ»ó È­ÇÐ
    • ±âŸ

Á¦8Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå : ¿ëµµº°

  • °³¿ä
    • ºÎ¹® Á¡À¯À² ºÐ¼® : ¿ëµµº°
    • â¾à ¹× °³¹ß
    • ü¿Ü Áø´Ü
    • ¿¬±¸

Á¦9Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
    • ºÎ¹® Á¡À¯À² ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
    • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • ¿¬±¸±â°ü
    • º´¿ø

Á¦10Àå ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ½ÃÀå : Áö¿ªº°

  • ¼­¹®
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ½Å°æ°úÇÐ ¿¬±¸¿ë Ç×ü ¹× ¾î¼¼ÀÌ ¾÷°è

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Abcam plc
    • Bio-Rad Laboratories
    • Cell Signaling Technology
    • MilliporeSigma
    • Agilent Technologies
    • BioLegend
    • Santa Cruz Biotechnology
    • OriGene Technologies
    • GenScript
    • R&D Systems
    • Novus Biologicals
    • RayBiotech
    • Rockland Immunochemicals
    • Others

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

AJY 24.09.12

REPORT HIGHLIGHT

Neuroscience Antibodies & Assays Market size was valued at USD 4,209.32 Million in 2023, expanding at a CAGR of 10.90% from 2024 to 2032.

Neuroscience antibodies and assays are kind of tools and techniques used in neuroscience research to study the nervous system at the molecular level. Neuroscience antibodies and assays play a crucial role in advancing our understanding of brain structure and function, aiding research into neurodevelopmental disorders, neurodegenerative diseases, and synaptic plasticity.

Neuroscience Antibodies & Assays Market- Market Dynamics

The growing prevalence of neurological disorders and investment in biotech industries are expected to fuel market demand

Neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, and others expand, and there is a growing need for tools that can accurately detect, and study biomarkers associated with these conditions. Neuroscience antibodies and assays play a crucial role in this research by enabling the identification and quantification of specific proteins, neurotransmitters, and other molecules implicated in disease mechanisms. Continuous advancements in antibody development, assay techniques, and imaging technologies have significantly enhanced the sensitivity, specificity, and multiplexing capabilities of neuroscience assays. This has broadened their application in both basic research and drug development efforts focused on neurological disorders.

Furthermore, increased investment from biotechnology and pharmaceutical companies into neuroscience research drives the demand for reliable tools like antibodies and assays, boosting the market growth. These companies rely on robust assays to validate drug targets, screen potential therapeutics, and assess treatment efficacy in preclinical and clinical studies. Thus, technological advancements, clinical needs, and economic incentives are expected to foster market growth.

Neuroscience Antibodies & Assays Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.90% over the forecast period (2024-2032)

Based on Technology segmentation, the immunoassays segment was predicted to show maximum market share in the year 2023, owing to its high prevalence of western blotting, and other immunology diseases.

Based on Application segmentation, the drug discovery & development segment was the leading Application in 2023, due to increased research in neuroscience and biotech applications.

Based on End User segmentation, pharmaceutical & biotech companies' segment was the leading End User in 2023, owing to increased investment from biotechnology and pharmaceutical companies.

On the basis of region, North America was the leading revenue generator in 2023, owing to higher investment in neuroscience in clinical diagnostics.

Neuroscience Antibodies & Assays Market- Segmentation Analysis:

The Global Neuroscience Antibodies & Assays Market is segmented on the basis of Technology, Application, End User, and Region.

The market is divided into four categories based on Technology: immunoassays, molecular diagnostics, clinical chemistry, and others. The immunoassays segment dominates the market. The high demand from ELISA, and western blotting types are contributing to segment growth.

The market is divided into three categories based on Application: drug discovery & development, in-vitro diagnostics, and research. The drug discovery & development segment dominates the market. The increasing number of novel drug discoveries and clinical diagnostics are fueling market growth.

The market is divided into three categories based on End Users: pharmaceutical & biotech companies, research institutes, and hospitals. The pharmaceutical & biotech companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Pharmaceutical companies are investing heavily in neuroscience and research supplementing market demand.

Neuroscience Antibodies & Assays Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a substantial share of the neuroscience antibodies and assays market, particularly the United States. This dominance is attributed to the presence of major pharmaceutical and biotechnology companies, extensive research funding from government agencies like NIH, and a well-established healthcare infrastructure.

Neuroscience Antibodies & Assays Market- Competitive Landscape:

The Neuroscience Antibodies & Assays market is moderately competitive in nature. Companies in the neuroscience antibodies and assays market continually innovate to enhance product performance and meet the evolving needs of researchers. Market players engage in strategic partnerships and collaborations to expand their product offerings and market reach. Existing market players focus on distribution channels to enhance product availability and customer support in key markets such as North America, Europe, and Asia-Pacific.

Recent Developments:

In September 2022, NIH has launched two transformative projects supported by BRAIN research initiative.

In July 2022, Pasithea Therapeutics got funding of USD 1.3 million for research in anti-integrin antibodies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Merck KGaA
  • Abcam plc
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • MilliporeSigma
  • Agilent Technologies
  • BioLegend
  • Santa Cruz Biotechnology
  • OriGene Technologies
  • GenScript
  • R&D Systems
  • Novus Biologicals
  • RayBiotech
  • Rockland Immunochemicals
  • Others

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032

  • Immunoassays
  • Molecular diagnostics
  • Clinical chemistry
  • Others

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Drug discovery & development
  • In-vitro diagnostics
  • Research

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Pharmaceutical & biotech companies
  • Research institutes
  • Hospitals

GLOBAL NEUROSCIENCE ANTIBODIES & ASSAYS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Neuroscience Antibodies & Assays Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neuroscience Antibodies & Assays Market Snippet by Technology
    • 2.1.2. Neuroscience Antibodies & Assays Market Snippet by Application
    • 2.1.3. Neuroscience Antibodies & Assays Market Snippet by End User
    • 2.1.4. Neuroscience Antibodies & Assays Market Snippet by Country
    • 2.1.5. Neuroscience Antibodies & Assays Market Snippet by Region
  • 2.2. Competitive Insights

3. Neuroscience Antibodies & Assays Key Market Trends

  • 3.1. Neuroscience Antibodies & Assays Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neuroscience Antibodies & Assays Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neuroscience Antibodies & Assays Market Opportunities
  • 3.4. Neuroscience Antibodies & Assays Market Future Trends

4. Neuroscience Antibodies & Assays Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neuroscience Antibodies & Assays Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Neuroscience Antibodies & Assays Market Landscape

  • 6.1. Neuroscience Antibodies & Assays Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neuroscience Antibodies & Assays Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Immunoassays
    • 7.1.3. Molecular diagnostics
    • 7.1.4. Clinical chemistry
    • 7.1.5. Others

8. Neuroscience Antibodies & Assays Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Drug discovery & development
    • 8.1.3. In-vitro diagnostics
    • 8.1.4. Research

9. Neuroscience Antibodies & Assays Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical & biotech companies
    • 9.1.3. Research institutes
    • 9.1.4. Hospitals

10. Neuroscience Antibodies & Assays Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Neuroscience Antibodies & Assays Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Neuroscience Antibodies & Assays Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Neuroscience Antibodies & Assays Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Neuroscience Antibodies & Assays Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Neuroscience Antibodies & Assays Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Neuroscience Antibodies & Assays Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Merck KGaA
    • 11.2.3. Abcam plc
    • 11.2.4. Bio-Rad Laboratories
    • 11.2.5. Cell Signaling Technology
    • 11.2.6. MilliporeSigma
    • 11.2.7. Agilent Technologies
    • 11.2.8. BioLegend
    • 11.2.9. Santa Cruz Biotechnology
    • 11.2.10. OriGene Technologies
    • 11.2.11. GenScript
    • 11.2.12. R&D Systems
    • 11.2.13. Novus Biologicals
    • 11.2.14. RayBiotech
    • 11.2.15. Rockland Immunochemicals
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦